# Fase F5 — Templates e Exemplos de Relatorio de Validacao

**Status**: COMPLETO
**Dependencias**: F3, F4
**Bloqueia**: Nenhuma

---

## Diretorio de Destino

`/home/guhaase/projetos/ModelRiskLab/mrl-content-files/content/en/report-templates/causal-inference/`

---

### 1. template.md

```markdown
---
slug: causal-inference-validation-report-template
name: "Validation Report Template — Causal Inference"
domain: causal-inference
type: report-template
status: draft
tags: [causal-inference, validation-report, template, did, rdd, iv, propensity-score, causal-forests, double-ml, e-value, sensitivity-analysis]
---

# Model Validation Report — Causal Inference

## 1. Executive Summary

## 2. Causal Question
### 2.1 Treatment Definition
### 2.2 Outcome Variable
### 2.3 Target Population
### 2.4 Estimand of Interest (ATE / ATT / CATE)

## 3. Data
### 3.1 Data Source and Period
### 3.2 Unit of Analysis
### 3.3 Treatment and Control Group Definitions
### 3.4 Sample Size and Attrition
### 3.5 Descriptive Statistics (pre-treatment covariates)

## 4. Identification Strategy
### 4.1 DAG with Explicit Assumptions
### 4.2 Method Chosen (DiD / RDD / IV / PSM / DML / Causal Forest)
### 4.3 Justification for Choice
### 4.4 Key Identifying Assumptions

## 5. Assumption Validation
### 5.1 Method-Specific Tests
#### DiD: Parallel Trends Test (pre-treatment)
#### RDD: Covariate Continuity at Cutoff, Bandwidth Selection
#### IV: Weak Instrument Test (F > 10), Exclusion Restriction Argument
#### PSM: Post-Matching Balance (Standardized Mean Differences)
#### DML: Cross-Fitting Diagnostics
### 5.2 Test Results and Interpretation

## 6. Estimation
### 6.1 Estimated Effect (ATE / ATT) with Confidence Intervals
### 6.2 Alternative Specifications
### 6.3 Comparison Across Methods (if applicable)

## 7. Sensitivity Analysis (E-Value)
### 7.1 E-Value Calculation
### 7.2 Rosenbaum Bounds (for matched studies)
### 7.3 Robustness to Unobserved Confounders
### 7.4 Sensitivity Contour Plot

## 8. Placebo Tests
### 8.1 Placebo Treatment in Pre-Treatment Period
### 8.2 Placebo Outcome on Unaffected Variable
### 8.3 Permutation Test Results
### 8.4 Falsification Test Results

## 9. Heterogeneous Effects
### 9.1 CATE by Subgroup
### 9.2 Feature Importance for Treatment Effect Heterogeneity
### 9.3 Policy-Relevant Subgroups

## 10. Conclusion and Recommendations
### 10.1 Overall Assessment of Causal Claim
### 10.2 Strength of Evidence
### 10.3 Limitations and Caveats
### 10.4 Conditions for Policy Implementation
### 10.5 Recommended Follow-Up Studies

## Appendices
### A. Full Regression Tables
### B. Balance Tables (Pre and Post Matching)
### C. Sensitivity Analysis Detailed Results
### D. Placebo Test Detailed Results
### E. Code and Reproducibility
### F. Data Dictionary
```

### 2. example.md — Exemplo Completo

Preencher com:
- **Cenario**: Avaliacao de impacto de programa de credito subsidiado sobre renda de beneficiarios
- **Metodo**: Difference-in-Differences (DiD)
- **Dados**: LaLonde NSW como proxy (tratamento = participacao no programa, outcome = renda)
- **Incluir**: parallel trends test, event study plot, estimacao ATE/ATT com intervalos de confianca, analise de sensibilidade E-value, placebo tests (tratamento falso em periodo pre), efeitos heterogeneos por subgrupo, conclusao com recomendacoes
- **Tom**: relatorio real para comite de validacao de modelos em instituicao financeira

---

## Criterios de Aceite

- [x] template.md criado com 10 secoes + appendices
- [x] template.md cobre causal question, identification strategy, assumption validation
- [x] template.md inclui estimation ATE/ATT com intervalos de confianca
- [x] template.md inclui sensitivity analysis com E-value
- [x] template.md inclui placebo tests
- [x] template.md inclui efeitos heterogeneos (CATE)
- [x] template.md inclui conclusion and recommendations
- [x] example.md preenchido com DiD para impacto de programa de credito
- [x] example.md tem parallel trends test e event study
- [x] example.md tem estimacao ATE/ATT com CI
- [x] example.md tem analise de sensibilidade E-value
- [x] example.md tem placebo tests
- [x] example.md tem efeitos heterogeneos por subgrupo
- [x] example.md tem conclusao e recomendacoes realistas
- [x] Ambos tem frontmatter YAML valido
- [x] Conteudo baseado em pesquisa web

---

**End of Specification**
